Clarified "Non-parallel" as a strong indicator of suspicious growth.
Now described as present or absent within a lesion or the immediate surrounding tissue. 💡 4. Practical Walkthrough for Patients BREAST ULTRASOUND: ACR BIRADS 5th EDITION WALKT...
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Clarified "Non-parallel" as a strong indicator of suspicious
✅ "Circumscribed," "Oval shape," "Parallel orientation," "Anechoic." Practical Walkthrough for Patients This is for informational
Determining if the patient returns in a year, 6 months, or needs a needle biopsy.
Anechoic (fluid), Hyperechoic (bright), Complex cystic/solid, Hypoechoic (dark), Isoechoic. Posterior Features: Enhancement, Shadowing, or No change. 📊 2. BI-RADS Assessment Categories Each scan is assigned a final assessment digit (0–6). Assessment Management Malignancy Risk 0 Incomplete Need more imaging/comparison 1 Routine screening 2 Routine screening 3 Probably Benign Short-interval follow-up (6 mo) 4 (A/B/C) Suspicious Tissue biopsy recommended 2% – 95% 5 Highly Suggestive Biopsy/Surgical action 6 Known Cancer Treatment planning 🔍 3. Key Changes in the 5th Edition
Finding a mass via physical exam or screening mammography.


















